James R. Jobe
Known title: DirectorCIK: 0001362322
James R. Jobe's purchase track record
James R. Jobe has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/30/2023 | NHI | $51K | +7.5% | +17.3% | +12.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NHI | ▼ Sell | Gift | 225 | $0 | 6/5/2026 | View on chart |
| NHI | ▲ Buy | Grant | 1,268 | $0 | 3/3/2026 | View on chart |
| NHI | ▲ Buy | Option Exercise | 10,000 | $733K | 2/17/2026 | View on chart |
| NHI | ▼ Sell | Tax Withholding | 8,058 | $733K | 2/17/2026 | View on chart |
| NHI | ▲ Buy | Option Exercise | 25,000 | $1.7M | 11/20/2025 | View on chart |
| NHI | ▼ Sell | Tax Withholding | 22,135 | $1.7M | 11/20/2025 | View on chart |
| NHI | ▲ Buy | Option Exercise | 25,000 | $1.3M | 8/23/2024 | View on chart |
| NHI | ▲ Buy | Option Exercise | 10,000 | $547K | 8/23/2024 | View on chart |
| NHI | ▲ Buy | Option Exercise | 10,000 | $578K | 8/23/2024 | View on chart |
| NHI | ▼ Sell | Tax Withholding | 31,289 | $2.5M | 8/23/2024 | View on chart |
| NHI | ▲ Buy | Open Market | 1,000 | $51K | 8/30/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
NHI Sets Q3 2026 Earnings Date Amid REIT Sector Pressure
National Health Investors has scheduled its third-quarter 2026 earnings release and conference call. This announcement comes as the broader REIT sector faces headwinds from interest rate sensitivity, noted in recent market commentary. The stock currently trades near its 52-week low, with a dividend yield of 6.63%.
NHI Sets Q3 2026 Earnings Date Amid REIT Sector Pressure. National Health Investors has scheduled its third-quarter 2026 earnings release and conference call. This announcement comes as the broader REIT sector faces headwinds from interest rate sensitivity, noted in recent market commentary. The stock currently trades near its 52-week low, with a dividend yield of 6.63%.